A three-stage biophysical screening cascade for fragment-based drug discovery


This protocol describes the screening of a library of low-molecular-weight compounds (fragments) using a series of biophysical ligand-binding assays. Fragment-based drug discovery (FBDD) has emerged as a successful method to design high-affinity ligands for biomacromolecules of therapeutic interest. It involves detecting relatively weak interactions between… (More)
DOI: 10.1038/nprot.2013.130


6 Figures and Tables

Blog articles referencing this paper

  • Review of 2013 reviews

    Practical Fragments · Dec 30, 2013

  • Don't see an article that should be here?

Slides referencing similar topics